SCHEMBL22334178

SCHEMBL22334178

CC(C)c1coc(C(F)F)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20713862 0.74
SCHEMBL24426852 0.73
SCHEMBL26776846 0.72
SCHEMBL22276368 0.72
SCHEMBL890082 0.70
SCHEMBL668578 0.68
SCHEMBL12248415 0.68
SCHEMBL10197111 0.68
SCHEMBL6797394 0.68
SCHEMBL25615230 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11820756-B2 Bradykinin B2 receptor antagonists Pharvaris Netherlands B.V. (NL) 2023-11-21 US disclosed
US-11820756-B2 Bradykinin B2 receptor antagonists Pharvaris Netherlands B.V. (NL) 2023-11-21 US disclosed
US-20220135543-A1 NOVEL BRADYKININ B2 RECEPTOR ANTAGONISTS Pharvaris Netherlands B.V. (NL) 2022-05-05 US disclosed
US-10836748-B2 Bradykinin B2 receptor antagonists Pharvaris Netherlands B.V. (NL) 2020-11-17 US disclosed
US-20200255405-A1 NOVEL BRADYKININ B2 RECEPTOR ANTAGONISTS ANALYTICON DISCOVERY GMBH (DE) 2020-08-13 US disclosed